PatentNext is a blog about Patent and Intellectual Property (IP) law focusing on Next-generation and New Age technologies.
PatentNext is moderated by Ryan N. Phelan, a registered U.S. Patent Attorney, who regularly publishes and speaks on IP law and modern technologies.
The @AIPLA recently published a white paper on a global perspective on software and medical device guidance, authored by partner Ryan Phelan and others on the AIPLA Augmented Reality(AR) / Virtual Reality(VR) subcommittee. https://t.co/GZaFw43y1w #virtualreality#augmentedreality
If an AI tool is used to draft patent claims, do you have to list the AI tool as an “inventor” or “joint inventor” on your patent application? Partner Ryan Phelan dives in with his latest blog post: https://t.co/DpYXpe8Svi #artificialintelligence#inventorship#software
Artificial Intelligence (AI)-generated music has the potential to reshape the music landscape. Partner Matthew Carey discusses why artists and listeners should be vigilant in navigating this evolving space. https://t.co/OAiGc3G97u #artificialintelligence#copyright#software
Stephen Thaler petitioned the U.S. Supreme Court to consider the question of whether AI could be listed as the sole inventor on a patent application. His petition has now been denied. https://t.co/bfzvpEGvRM #inventorship#software
PatentNext's latest article explores the ethical considerations of artificial intelligence (AI) and the White House's Blueprint for an AI Bill of Rights:: https://t.co/Dt0fvbuSRY #artificialintelligence#patents#software
A quick look at how courts view Virtual Reality (VR) inventions in the age of the Metaverse: https://t.co/ntAZcXM0WN #software#metaverse#virtualreality
The European Patent Office (#EPO) recently suggested that the owner of an Artificial Intelligence (AI) machine could be listed as the inventor of an AI-generated invention. https://t.co/ha3vwNz4Wn #artificialintelligence#inventions#software
Metaverse patenting had an early start in video game technology, and patent cases in this space provide a preview of future #Metaverse court cases https://t.co/f91WN6e0rQ #software#patents
New Zealand, the EPO, and the UK allow an Artificial Intelligence (AI) machine to be listed as a Joint Inventor along with at least one Human Inventor https://t.co/V5m06KrZE1 #artificialintelligence#inventions
Marshall Gerstein partner Ryan Phelan co-authors @IPO white paper on Best Practices for Protecting Inventions Relating to Artificial Intelligence (AI) https://t.co/XhjT681wl9 #artificialintelligence#software#patents
U.S. Patent Office announces a new pilot program that will allow patent applicants to defer responding to Office Actions that include issues of subject matter eligibility (SME) under 35 USC 101/Alice. https://t.co/aKiIJdIPJm #subjectmattereligibility#USPTO
The second part of this article series focusing on Software-based Medical Devices focuses on “data processing.” Click through to see the do’s-and-don’ts as illustrated by a pair of Federal Circuit decisions. https://t.co/uLUKWOvsqm #medicaldevices#software
In an earlier post, we explored how an artificial intelligence (AI) invention was found invalid for lack of sufficient disclosure; find out how a U.S. district court treated a similar issue, but for a different patent. https://t.co/aNz4PK2NOT #artificialintelligence
Can an AI-related invention receive different treatment in the U.S. and the EPO? Click through for a discussion on this topic. https://t.co/aFd5i75uYY #artificialintelligence#software
Given that software-related inventions involve source and/or object code, should you include an algorithm in your patent specification? If you don’t, what risks can arise? Click through to view this article (pt. 2) of a 2-part series. https://t.co/XsqfM7jQLy #software#inventions
Patenting #medicaldevices that include #software can require special considerations for demonstrating patent eligibility. This article explores these considerations, and provides example cases and describes emerging FDA outlook on this topic. Learn more: https://t.co/wtuXLuTpYF